LIVE BLOG
Economic Times | 29 Jul, 2020 | 06.26AM IST
Coronavirus Live News: 57% slum residents have had COVID-19 in Mumbai
The study estimate around 57 per cent Sero-prevalence in slums and 16 per cent sero-prevalence in non-slums, on an average, in the three wards that were studied.
!1 New UpdateClick here for latest updates
Moderna aims to price coronavirus vaccine at $50-$60 per course
- Moderna Inc is planning to price its coronavirus vaccine at $50 to $60 per course, at least $11 more than another vaccine from Pfizer Inc and BioNTech, the Financial Times reported on Tuesday, citing unnamed sources.
- Moderna’s proposed price for a two-dose course sold to governments compares with $39 for two doses under a deal that Pfizer Inc and German partner BioNTech struck with the U.S. government.
US daily virus death toll reaches nearly 1,600, highest rate in 2.5 months: Johns Hopkins
Mumbai survey finds 57% have had COVID-19 in slums
- A total of 6,936 samples were collected from 3 wards in slums and non-slums in the first round of Serological Surveillance for SARS-CoV2 commissioned by NITI-Aayog, Municipal Corporation of Greater Mumbai (MCGM) and Tata Institute of Fundamental Research (TIFR), said Brihanmumbai Municipal Corporation (BMC) on Tuesday.
- The systematically conducted study estimate around 57 per cent Sero-prevalence in slums and 16 per cent sero-prevalence in non-slums, on average, in the three wards that were studied.
1,371 new COVID-19 cases in Assam
Earthquake with 2.8 magnitude hits Maharashtra's Palghar district
Record 212 environmental activists killed in 2019: Watchdog
AFP
